Observations placeholder
Pemetrexed
Identifier
019834
Type of Spiritual Experience
Background
A description of the experience
Pemetrexed (brand name Alimta) is a chemotherapy drug used in the treatment of pleural mesothelioma and non-small cell lung cancer.
Side effects
Pemetrexed, whether used alone or in combination with cisplatin, has these side effects:
- Low blood cell counts, as measured by a complete blood count. This is a dose-limiting toxicity.
- Mental fatigue and sleepiness. Fatigure can be reduced through an off-label prescription of Provigil.
- Nausea and vomiting. Pemetrexed's emetogenic effects are managed with prophylactic antiemetics.
- Diarrhea
- Oral mucositis (mouth, throat, or lip sores). Oral ulcers can be mitigated by proper oral hygiene, including rinsing of the mouth with salt water following consumption of food or drink Loss of appetite
- Skin rash. Physician-prescribed steroids administered on the day prior, day of, and day after infusion typically avoid skin rashes.
- Constipation
On Jan, 5, 2016: 2,635 people reported to have side effects when taking Pemetrexed. Among them, 1 people (0.04%) has Hallucination.
On Jan, 28, 2016: 2,635 people reported to have side effects when taking Pemetrexed. Among them, 160 people (6.07%) have Death.
Time on Pemetrexed when people have Death :
< 1 month | 1 - 6 months | 6 - 12 months | 1 - 2 years | 2 - 5 years | 5 - 10 years | 10+ years | |
Death | 41.94% | 53.23% | 4.84% | 0.00% | 0.00% | 0.00% | 0.00% |
Age of people who have Death when taking Pemetrexed :
0-1 | 2-9 | 10-19 | 20-29 | 30-39 | 40-49 | 50-59 | 60+ | |
Death | 0.00% | 0.00% | 0.00% | 0.00% | 2.04% | 5.44% | 25.17% | 67.35% |
Top conditions involved for these people :
- Non-small cell lung cancer (105 people, 65.62%)
- Prophylaxis (65 people, 40.62%)